Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia

[1]  S. Sarafianos,et al.  Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance? , 2006, PLoS pathogens.

[2]  W. Heneine,et al.  Natural resistance of human immunodeficiency virus type 2 to zidovudine. , 2005, Virology.

[3]  S. Popper,et al.  Highly active antiretroviral therapy and viral response in HIV type 2 infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  P. Colson,et al.  Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern France , 2004, Journal of Clinical Microbiology.

[5]  A. Blaxhult,et al.  pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. , 2003, AIDS research and human retroviruses.

[6]  S. Kaye.  Simple PCR-based method for synthesis of molecular calibrators and controls. , 2003, Clinical chemistry.

[7]  B. Rodés,et al.  Prevalence of G333D/E in naive and pretreated HIV-infected patients. , 2002, AIDS research and human retroviruses.

[8]  F. Antunes,et al.  Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2-Infected Subjects Undergoing Antiretroviral Therapy , 2000, Journal of Clinical Microbiology.

[9]  H. Whittle,et al.  Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. , 1998, Journal of human virology.

[10]  John W. Mellors,et al.  A Novel Polymorphism at Codon 333 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Can Facilitate Dual Resistance to Zidovudine and l-2′,3′-Dideoxy-3′-Thiacytidine , 1998, Journal of Virology.

[11]  F. Brun-Vézinet,et al.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses , 1997, Journal of virology.

[12]  D. Kuritzkes,et al.  Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter , 1995 .

[13]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[14]  J. Nkengasong,et al.  HIV antiretroviral drug resistance in Africa. , 2004, AIDS reviews.